NCT06001788 2026-04-14Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaKura Oncology, Inc.Phase 1 Recruiting171 enrolled
NCT06152809 2026-03-18CIML NK Cells With Venetoclax for AMLDana-Farber Cancer InstitutePhase 1 Recruiting10 enrolled